Change in the Managing Director's responsibilities to Head of Research and Development
First written in FY2017-Q3. 1 of 3 entries say "Restated". Latest entry: FY2022.
PhoenixBio moved to the "Worse" side of this theme in 2022, 2 years before the typical company in this theme (2024).
The whole theme swung hardest in 2026: 4 of 26 companies on the "Worse" side.
8 other companies' latest entry also says "Reframed".
- FY2022ReframedAnnual report
「April 2022 Executive Director, General Manager of Research and Development and General Manager of Production」
Mukaiya Tomoyo (向谷知世)'s responsibilities were expanded from General Manager of Research and Development to General Manager of Research and Development and General Manager of Production. - FY2017RestatedAnnual report
「Executive Director General Manager, Research and Development／General Manager, Research and Development／Mukaiya Tomoyo (向谷 知世)／1 July 2016」
The appointment of Executive Director Mukaiya Tomoyo (向谷知世) as General Manager of Research and Development, effective 1 July 2016, is reconfirmed under the current executive structure. - FY2017-Q3First statedAnnual report
「Executive Director General Manager, Research and Development／Executive Director General Manager, Production General Manager, Research and Development／Mukaiya Tomoyo (向谷 知世)／1 July 2016」
The change in responsibility of Executive Director Mukaiya Tomoyo (向谷知世) to General Manager of Research and Development, effective 1 July 2016, is reported as a change in the executive structure.